Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide for injection. It also provides isosorbide mononitrate sustained-release tablets; and oxygen rhodiola rosea moisturizing essence, secret recipe fragrance powder packet, rhodiola rosea, and Yuan Yang rhodiola rosea moisturizing essence products. In addition, the company offers biopharmaceuticals, traditional Chinese medicine, and chemical drugs for various fields, such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines. The company was founded in 1999 and is headquartered in Lhasa, China.
Frequently asked questions
What sector does Tibet Rhodiola Pharmaceutical Holding Co (600211) operate in?
Tibet Rhodiola Pharmaceutical Holding Co belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Tibet Rhodiola Pharmaceutical Holding Co (600211) current stock price?
As of the latest data, Tibet Rhodiola Pharmaceutical Holding Co stock price is CN¥37.54, with a previous close of CN¥37.31. Tibet Rhodiola Pharmaceutical Holding Co gained CN¥0.23 in the last trading session, representing a 0.62% increase.
What is Tibet Rhodiola Pharmaceutical Holding Co (600211) current market capitalization?
Tibet Rhodiola Pharmaceutical Holding Co market cap is approximately 12.10 billion.
What is Tibet Rhodiola Pharmaceutical Holding Co (600211) Earnings Per Share (EPS)?
The trailing EPS is CN¥3.06.
What is Tibet Rhodiola Pharmaceutical Holding Co (600211) Price-to-Earnings (P/E) ratio?
Tibet Rhodiola Pharmaceutical Holding Co current P/E ratio is 12.27.
Does Tibet Rhodiola Pharmaceutical Holding Co (600211) pay dividends?
No. Tibet Rhodiola Pharmaceutical Holding Co does not pay a dividend.
What is Tibet Rhodiola Pharmaceutical Holding Co (600211) beta (volatility) score?
Tibet Rhodiola Pharmaceutical Holding Co has a beta of 0.217, indicating lower volatility than the overall market.
